Benzinga's Small Cap Movers for Tuesday March 5, 2013

Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Galectin Therapeutics Shares of Galectin Therapeutics (NASDAQ: GALT ), the Norcross, GA developer of therapeutics that target galectin proteins to treat fibrosis and cancer, rose 14% at one point on Tuesday on 3.5 times average volume. Galectin